Description

BSE announces the live activities schedule for the Offer to Buy (Takeover) acquisition window for ASPIRA PATHLAB & DIAGNOSTICS LTD (ASPIRA), open from 15th April 2026 to 28th April 2026 at Rs. 55.00 per share for up to 26,76,180 equity shares.

Summary

BSE has announced the live activities schedule for the Offer to Buy (OTB) – Acquisition Window (Takeover) for ASPIRA PATHLAB & DIAGNOSTICS LTD (Symbol: ASPIRA, Scrip Code: 540788, ISIN: INE500C01017). The offer window is open from Wednesday, 15th April 2026 to Tuesday, 28th April 2026, with an offer price of Rs. 55.00 per share for up to 26,76,180 equity shares.

Key Points

  • Security: ASPIRA PATHLAB & DIAGNOSTICS LTD (ASPIRA), Scrip Code 540788, ISIN INE500C01017
  • Offer Size: Up to 26,76,180 equity shares
  • Offer Price: Rs. 55.00 per share
  • Face Value: Rs. 10.00
  • Market Lot: 1
  • Opening Date: Wednesday, 15th April 2026
  • Closing Date: Tuesday, 28th April 2026
  • Live OTB session bid offering runs 9:15 a.m. to 3:30 p.m. daily
  • Give-up/Take-up modifications allowed from 15th–27th April 2026 (9:15 a.m. to 3:30 p.m.)
  • Last day give-up (28th April): 9:15 a.m. to 3:30 p.m.; last day take-up: 9:15 a.m. to 4:00 p.m.
  • Modification and cancellation of bids: Not Allowed

Regulatory Changes

No new regulatory changes are introduced. This notice operationalises the existing OTB – Acquisition Window (Takeover) framework as per Exchange Notices 20150930-1 (dated 30 September 2015) and 20170203-29 (dated 3 February 2017).

Compliance Requirements

Important Dates

EventDate / Period
Offer Opening DateWednesday, 15th April 2026
Offer Closing DateTuesday, 28th April 2026
Bid Offering Period15th April 2026 – 28th April 2026 (9:15 a.m. – 3:30 p.m.)
Give-up / Take-up (Modification)15th April 2026 – 27th April 2026 (9:15 a.m. – 3:30 p.m.)
Last Day Give-up28th April 2026 (9:15 a.m. – 3:30 p.m.)
Last Day Take-up28th April 2026 (9:15 a.m. – 4:00 p.m.)

Impact Assessment

This circular directly impacts shareholders and trading/custodian members dealing in ASPIRA PATHLAB & DIAGNOSTICS LTD (Scrip Code: 540788). The takeover offer at Rs. 55.00 per share for up to 26,76,180 shares represents a significant liquidity event for existing shareholders. Trading members must ensure operational readiness on the iBBS and RTRMS platforms for the two-week offer window. Eligible investor categories include FII, FI, MF, IC, OTH, NOH, CO, and IND. Members should take note of the strict no-modification/cancellation policy and the differing session end times on the final day.

Impact Justification

This is a live takeover acquisition window notice directly affecting ASPIRA PATHLAB & DIAGNOSTICS LTD shareholders and trading members. The offer involves up to 26,76,180 shares at Rs. 55.00 per share, with specific session timings and operational requirements for trading and custodian members.